Du Xiaotian, Liang Kejiong, Ding Shili, Shi Haifei
Department of Orthopedic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Biomedicines. 2023 Sep 6;11(9):2467. doi: 10.3390/biomedicines11092467.
Low back pain is the leading cause of disability worldwide. Intervertebral disc degeneration (IDD) is the primary clinical risk factor for low back pain and the pathological cause of disc herniation, spinal stenosis, and spinal deformity. A possible approach to improve the clinical practice of IDD-related diseases is to incorporate biomarkers in diagnosis, therapeutic intervention, and prognosis prediction. IDD pathology is still unclear. Regarding molecular mechanisms, cellular signaling pathways constitute a complex network of signaling pathways that coordinate cell survival, proliferation, differentiation, and metabolism. Recently, stem cells have shown great potential in clinical applications for IDD. In this review, the roles of multiple signaling pathways and related stem cell treatment in IDD are summarized and described. This review seeks to investigate the mechanisms and potential therapeutic effects of stem cells in IDD and identify new therapeutic treatments for IDD-related disorders.
腰痛是全球致残的主要原因。椎间盘退变(IDD)是腰痛的主要临床风险因素,也是椎间盘突出、椎管狭窄和脊柱畸形的病理原因。改善IDD相关疾病临床实践的一种可能方法是将生物标志物纳入诊断、治疗干预和预后预测。IDD的病理仍不清楚。关于分子机制,细胞信号通路构成了一个复杂的信号通路网络,协调细胞存活、增殖、分化和代谢。最近,干细胞在IDD的临床应用中显示出巨大潜力。在这篇综述中,总结并描述了多种信号通路和相关干细胞治疗在IDD中的作用。本综述旨在研究干细胞在IDD中的作用机制和潜在治疗效果,并确定IDD相关疾病的新治疗方法。